BRENTUXIMAB VEDOTIN IN THE TREATMENT OF ELDERLY HODGKIN LYMPHOMA PATIENTS AT FIRST RELAPSE OR WITH PRIMARY REFRACTORY DISEASE: A PHASE 2 STUDY OF FIL ONLUS

HAEMATOLOGICA(2019)

引用 2|浏览37
暂无评分
关键词
Cell Therapy and Immunotherapy,Hodgkin's Lymphoma,brentuximab vedotin,elderly
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要